CA
IDXX icon

Centerpoint Advisors’s Idexx Laboratories IDXX Stock Holding History

Centerpoint Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed -$1K – 504
2023
Q3 		$1K Hold
2
– – ﹤0.01% 505
2023
Q2 		$1K Hold
2
– – ﹤0.01% 507
2023
Q1 		$1K Buy
+2
New +$957 ﹤0.01% 503
2020
Q3 		– Sell
-21
Closed -$7K – 251
2020
Q2 		$7K Buy
+21
New +$6.08K 0.01% 171
2018
Q3 		– Sell
-7
Closed -$2K – 299
2018
Q2 		$2K Buy
+7
New +$1.44K ﹤0.01% 304

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Centerpoint Advisors's IDXX Position: Q4 2023 in Review

Centerpoint Advisors sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 2 shares — an estimated $1K sold.

Centerpoint Advisors first reported a position in IDXX in Q2 2018 and held it in 5 quarters. The position peaked at $7K in Q2 2020. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Centerpoint Advisors reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Centerpoint Advisors sold 2 Idexx Laboratories shares in Q4 2023, an estimated $1K.
  • Centerpoint Advisors first reported a position in Idexx Laboratories in Q2 2018 and held it in 5 quarters.
  • Centerpoint Advisors's Idexx Laboratories position peaked at $7K in Q2 2020.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Centerpoint Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.